You are here

Gouri Shankar Bhattacharyya (IN)

In-charge, Department of Medical Oncology, at FORTIS Hospital, Anandapur, Kolkata – 700107, India.
As well as at Salt Lake City Medical Centre, DD-10, Sector 1, Salt Lake, Kolkata – 700 064, India

Conferred

•          Fellow of Academy of European Society for the Translational Medicine (EUSTM) - FAcadTM
•          Fellow of The American Society for Pharmacology and Experimental Therapeutics (F-ASPET)
•          Royal College of Obstetricians and Gynecologists (RCOG) Associate
•          Fellow of American College Clinical Pharmacology

He has completed his education and training in Medical Oncology from England. His line of special interest has been – Biological Response Modifiers and Tumour Microenvironment.

His principal interest is in Solid Tumours – G.I., Breast and Lung, repurposing of drugs. He is a member of the Task Force for Management of Cancer at the Indian Council for Medical Research (Government of India) as well as a member of the Planning Committee of the National Cancer Control Program. He is the founder member of Indian Cooperative Oncology Network (ICON), Molecular Oncology Society, and Indian Association of Cancer Research. He is also the founder Member of ICON Biorepository as well as member for Drafting of SOPs. He is the Immediate Past President of Indian Society of Medical & Paediatric Oncology.

He is an Advisory Council Member of the Breast International Group (BIG) as well as member of BIG-North American Breast Cancer Group (BIG-NABCG) and Drafting Committee Member of Consent Guidelines for Biorepository. He is the member of the American School of Clinical Oncology (ASCO), ASCO International Member Liaisons Program of ASCO International Affairs Committee; Reviewer for the American Journal of Clinical Oncology; European Society for Medical Oncology (ESMO) where he is the Global Policy Committee - Member, Global Cancer Task Force Member,ESMO Coordinator for ESMO Global Opioid Policy Initiative member and Member ESMO-EAPC Joint Executive Committee. He is Member & Governance (Steering Committee) – Low Middle-Income Countries-Guidelines International Network (G-I-N).

He is Chairman of the SIOG Publication Committee as well as SIOG Governance Council Member. He is Publication Committee Member of International Association for the Study of Lung Cancer (IASLC). He is Editorial Board Member of Journal of Thoracic Oncology (JTO), Journal of Geriatric Oncology, Critical Reviews in Oncology/ Hematology (CROH), Journal of Global Oncology–ASCO, Journal of Annals of Translational Medicine. He has special interest in Palliative Care and Geriatric Oncology. He has been awarded Certificate of Recognition for Promotion and Development of Palliative Care in the World in 2013, by International Association for Hospice & Palliative Care (IAHPC). He is the Executive Council Member of International Cardi-Oncological Society (ICOS). He is a member of the Steering Committee of World Health Organization (WHO) for Oncology. He has also received the Accreditation – 2015 ESMO Designated Centre of Integrated Oncology and Palliative Care. He is Executive Committee Member of Indian Lung Cancer Study Group; Publication Committee Member of Indian Society for Study of Lung cancer (ISSLC); Reviewer for Lung India, Official publication of Indian Chest Society. He is Member Oncology Outcome Group/ South East Asia Committee Member of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Reviewer for International Society for Pharmacoeconomics and Outcomes Research (ISPOR); Reviewer for the Asian Journal of Clinical Oncology; Reviewer for International Journal of Gynecological Cancer (IJGC)

He is

  • Member Indian Council of Medical Research (ICMR) Task Force for Management of cancer (Govt. of India)
  • Chairman Task Force (ICMR) for CLL and Low Grade cancer (Govt. of India)
  • National Cancer Control Program (Govt. of India)
  • Advisory Board Member to Drug Controller General of India (DCGI), (Govt. of India)
  • Faculty Member to Clinical Development Services Agency (CDSA) and Department of Biotechnology (DBT) (Govt. of India)
  • NCI-NIH, USA – Task Force Member for Gastro-intestinal cancer and Hepato-biliary cancer
  • Member of Global mBC Taskforce and Global Advanced Breast Cancer Alliance

He has published more than 200 papers and has been an Investigator for more than 50 Phase II and III Clinical Trials done including Translational Research. He is holder of Orphan Drug status with FDA for Hepato-cellular carcinoma, Pancreatic Cancer and Glioma based on Investigator initiated trials.

November 10, 2017
2:30pm to 3:30pm Multicultural perspective on cancer care Warsaw IV & V Gouri Shankar Bhattacharyya (IN), Etienne Brain (FR), Theodora Karnakis (BR), Adam Pluzanski (PL)